The above results showed that USP7-YY1 interaction was involved in the malignant progression of HCC, supporting the possibility that targeting USP7-mediated YY1 ubiquitination may be a strategy for HCC treatment. This evidence concerns the gene YY1 and hepatocellular carcinoma.